BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1849542)

  • 1. [Analysis of prognostic factors in high risk gestational trophoblastic disease with respect to remission and recurrence].
    Matsui H; Kobayashi O; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):131-7. PubMed ID: 1849542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen.
    Kim SJ; Bae SN; Kim JH; Kim CJ; Jung JK
    Gynecol Oncol; 1998 Nov; 71(2):247-53. PubMed ID: 9826467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission rates and significance of prognostic factors in gestational trophoblastic tumors.
    Ayhan A; Yapar EG; Deren O; Kişnişçi H
    J Reprod Med; 1992 May; 37(5):461-5. PubMed ID: 1324312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental site trophoblastic tumor: an overview.
    Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
    J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mono and polichemotherapy in the treatment of metastatic and invasive gestational trophoblastic disease: analysis of 50 cases.
    de Andrade JM; Murta EF; de Freitas MM; Pires CR; Bighetti S
    Rev Paul Med; 1993; 111(6):433-8. PubMed ID: 7519787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985.
    DuBeshter B; Berkowitz RS; Goldstein DP; Cramer DW; Bernstein MR
    Obstet Gynecol; 1987 Mar; 69(3 Pt 1):390-5. PubMed ID: 3029641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
    Soper JT; Clarke-Pearson D; Hammond CB
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein M
    J Reprod Med; 1989 Mar; 34(3):189-92. PubMed ID: 2470902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
    Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
    Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the recurrent trophoblastic disease].
    Takamizawa H; Kobayashi O; Katoh T; Shirotake S; Endou N; Ishige H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1729-35. PubMed ID: 6294193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management and risk factors of recurrent gestational trophoblastic tumor].
    Yang JJ; Xiang Y; Wan XR; Shi JR; Wei SM; Yang XY
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):52-5. PubMed ID: 16606539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk metastatic gestational trophoblastic disease.
    Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
    Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
    Mortakis AE; Braga CA
    Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia].
    Wang YX; Zhang X; Guan YL; Jang AY; Long ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):87-90. PubMed ID: 15840285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.